Minimizing Glucocorticoid Administration in Patients With Proliferative Lupus Nephritis

Abroad (travel likely)RecruitingPHASE4

Conditions

Lupus Nephritis

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Fundeni Clinical Institute, Bucharest, Romania
Contact: Study coordinator (Bogdan Obrisca, MD, PhD) · obriscabogdan@yahoo.com · 0040721256797

Study leads

Gener Ismail, MD, PhD
Principal Investigator
Institutul Clinic Fundeni

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

PRESERVE: LUPKYNIS in Combination With Belimumab, Obinutuzumab or Anifrolumab in Patients With Lupus Nephritis

Lupus Nephritis

Abroad (travel likely)RecruitingPHASE4

La Mesa, United States · Los Alamitos, United States

Induction Therapy for Lupus Nephritis With no Added Oral Steroids: A Trial Comparing Oral Corticosteroids Plus Mycophenolate Mofetil (MMF) Versus Obinutuzumab and MMF

Lupus Nephritis · Systemic Lupus Erythematosus (SLE)

Abroad (travel likely)RecruitingPHASE3

Paris, France

Dapagliflozin in Active Lupus Nephritis

Lupus Nephritis (LN)

Abroad (travel likely)RecruitingPHASE4

Boston, United States · Boston, United States

Safety and Efficacy of Combination Belimumab and Voclosporin in the Treatment of Proliferative Forms of Lupus Glomerulopathy: Synergy Trial

Lupus Nephritis

Abroad (travel likely)RecruitingPHASE4

Glendale, United States · Atlanta, United States